Document is current
Any future updates will be listed below
-
Authors
Elkoush, A.
Giossi, R.
Gadaleta, G.
Maccabeo, A.
Pinna, F.
Palladino, A.
Giannotta, M.
Leone, D.
Colacicco, G.
Risi, B.
Gibertini, S.
Verriello, L.
Panicucci, C.
Bruno, C.
Pane, M.
Messina, S.
Rodolico, C.
Pini, A.
Vattemi, G.
Filosto, M.
Padovani, A.
Sansone, V. A.
Carella, M. C.
Forleo, C.
Tonin, P.
Fiorillo, C.
Politano, L.
Carboni, N.
Mongini, T.
Maggi, L. https://orcid.org/0000-0002-0932-5173
-
Funding
Funding for this research was provided by:
Ministero della Salute
- License Information
-
More Information
Article History
Received: 21 January 2026
Revised: 14 April 2026
Accepted: 17 April 2026
First Online: 28 April 2026
Declarations
:
: Dr. Giossi received support for congress participation from Mylan, acted as a consultant for C.I.R.M.-Consorzio Italiano per la Ricerca in Medicina, Daiichi-Sankyo, and SOBI; and received fees for speaking from Alexion-AstraZeneca and argenx, outside this work. Dr. Maggi has received honoraria for speaking, advisory boards and compensation for congress participation from Sanofi, Roche, Biogen, Amicus Therapeutics, Alexion, Argenx, UCB, Johnson & Johnson, Lupin, outside the present work. Prof. Rodolico has received honoraria for advisory boards and compensation for congress participation from Alexion, argenx, Johnson & Johnson, UCB Pharma, outside the submitted work.
